文献速递慢阻肺

基于CT的气道表面积与体积比用于慢阻肺气道重塑表型分析

Computed Tomography-based Airway Surface Area-to-Volume Ratio for Phenotyping Airway Remodeling in Chronic Obstructive Pulmonary Disease.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01

本研究在COPDGene队列中分析4,325例慢阻肺患者和73名非吸烟者的气道树,计算气管下气道树的表面积与体积比(SA/V)。SA/V与FEV1/FVC、FEV1%预计值、6分钟步行距离、呼吸生活质量及肺功能下降独立相关;5年内SA/V下降(以气道丢失为主)者较SA/V升高(以气道狭窄为主)者全因死亡风险更高。

要点

  • CT衍生的气道SA/V与慢阻肺患者肺功能、运动能力和生活质量独立相关。
  • 5年内SA/V下降提示以气道丢失为主,与更差生存相关。
  • SA/V可作为慢阻肺气道重塑的影像生物标志物区分狭窄与丢失。

核心结论

  • 基于CT的气道SA/V是气道重塑的影像生物标志物,可区分慢阻肺中以气道狭窄为主和以气道丢失为主的不同表型。
  • SA/V与呼吸系统疾病负担、肺功能下降和生存相关。

研究设计与样本

  • 多中心COPDGene队列分析,纳入4,325例COPD全球倡议0至4期患者和73名非吸烟者。
  • 估计气管下气道树的表面积和体积以得出SA/V,并进行多变量回归分析。
  • 根据5年内SA/V变化将受试者分为以气道狭窄为主[∆(SA/V)大于0]和以气道丢失为主[∆(SA/V)小于0]两组并比较生存。

主要发现

  • 气道SA/V与FEV1/FVC独立相关(β=0.12;95%CI 0.09-0.14;P<0.001)。
  • 气道SA/V与FEV1%预计值独立相关(β=20.10;95%CI 15.13-25.08;P<0.001)。
  • 气道SA/V还与6分钟步行距离、呼吸生活质量及肺功能下降独立相关。
  • 与以气道狭窄为主者(n=2,914;66.3%)相比,以气道丢失为主者(n=1,484;33.7%)生存更差(全因死亡调整风险比=1.58;95%CI 1.18-2.13;P=0.002)。

临床怎么用

  • 可利用CT测量的气道SA/V辅助识别慢阻肺患者中以气道丢失为主的高死亡风险表型。
  • SA/V变化可能帮助临床评估气道重塑方向并指导随访强度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Airway remodeling in chronic obstructive pulmonary disease (COPD) is due to luminal narrowing and/or loss of airways. Existing computed tomographic metrics of airway disease reflect only components of these processes. With progressive airway narrowing, the ratio of the airway luminal surface area to volume (SA/V) should increase, and with predominant airway loss, SA/V should decrease.Objectives: To phenotype airway remodeling in COPD.Methods: We analyzed the airway trees of 4,325 subjects with COPD Global Initiative for Chronic Obstructive Lung Disease stages 0 to 4 and 73 nonsmokers enrolled in the multicenter COPDGene (Genetic Epidemiology of COPD) cohort. Surface area and volume measurements were estimated for the subtracheal airway tree to derive SA/V. We performed multivariable regression analyses to test associations between SA/V and lung function, 6-minute-walk distance, St. George's Respiratory Questionnaire, change in FEV1, and mortality, adjusting for demographics, total airway count, airway wall thickness, and emphysema. On the basis of the change in SA/V over 5 years, we categorized subjects into predominant airway narrowing [positive ∆(SA/V) more than 0] and predominant airway loss [negative ∆(SA/V) less than 0] and compared survival between the two groups.Measurements and Main Results: Airway SA/V was independently associated with FEV1/FVC (β = 0.12; 95% confidence interval [CI], 0.09-0.14; P < 0.001) and FEV1% predicted (β = 20.10; 95% CI, 15.13-25.08; P < 0.001). Airway SA/V was also independently associated with 6-minute-walk distance, respiratory quality of life, and lung function decline. Compared with subjects with predominant airway narrowing (n = 2,914; 66.3%), those with predominant airway loss (n = 1,484; 33.7%) had worse survival (adjusted hazard ratio for all-cause mortality = 1.58; 95% CI, 1.18-2.13; P = 0.002).Conclusions: Computed tomography-based airway SA/V is an imaging biomarker of airway remodeling and provides differential information on predominant airway narrowing and loss in COPD. SA/V is associated with respiratory morbidity, lung function decline, and survival.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Bodduluri S, Kizhakke Puliyakote A, Nakhmani A, et al. Computed Tomography-based Airway Surface Area-to-Volume Ratio for Phenotyping Airway Remodeling in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021. PMID: 32755486. doi:10.1164/rccm.202004-0951OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。